Thread: Help Scott Brown win in Massachusetts!

You Can Help Make History

On January 19th, a special election will be held in
Massachusetts to fill the vacated seat of the late
Senator Ted Kennedy. As most of us realize, it can
have a profound impact on the nation, as well as
Massachusetts.

Until a few weeks ago, it appeared that Martha
Coakley would easily win Kennedy’s seat and
extend the Democratic stranglehold.

However, in the ensuing weeks, Republican
Scott Brown has closed the gap so dramatically
that, according to several polls, he is now in a
DEAD HEAT. A key reason for Brown’s success
is the intensive use of “phone banksâ€

The Plum LineGreg Sargent's blog
Internal Memo To Top Dem Donors Warns Mass Senate Race Is “Very Tight,â€

January 12th, 2010
Ruh-roh
Posted by Tom Bevan
Greg Sargent got his grubby mitts on an internal memo from the Coakley campaign that is most interesting: Internal Memo To Top Dem Donors Warns Mass Senate Race Is “Very Tight,â€

Coakley in trouble? Pharma and HMO lobbyists to the rescue and more: GET THIS OUT A.S.A.P

Coakley in trouble? Pharma and HMO lobbyists to the rescue

GET IT TO Scott Brown fast... get it out by emails and blog A.S.A.P

Read more at the Washington Examiner: http://www.washingtonexaminer.com/opini ... fidentia...

By: Timothy P. Carney
Examiner Columnist
01/09/10 1:55 PM EST

confidential/Coakley-in-trouble-Pharma-and-HMO-lobbyists-to-the-rescue-

With Democrat Martha Coakley in trouble in the Massachusetts special election to fill Ted Kennedy's seat, Democrats could lose vote No. 60 for President Obama's health-care bill. In response, an army of lobbyists for drug companies, health insurance companies, and hospitals has teamed up to throw a high-dollar Capitol Hill fundraiser for Coakley next Tuesday night. The invitation is at right (click here for a better view).http://media.sfexaminer.com/images/COAKLEY.JPG

Of the 22 names on the host committee--meaning they raised $10,000 or more for Coakley--17 are federally registered lobbyists, 15 of whom have health-care clients. Of the other five hosts, one is married to a lobbyist, one was a lobbyist in Pennsylvania, another is a lawyer at a lobbying firm, and another is a corporate CEO. Oh, and of course, there's also the political action commitee for Boston Scientific Corporation.

All the leading drug companies have lobbyists on Coakley's host committee: Pfizer, Merck, Amgen, Sanofi-Aventis, Eli Lilly, Novartis, Astra-Zeneca, and more. On the insurance side of things, Blue Cross/Blue Shield, Cigna, Humana, HealthSouth, and United Health all are represented on the host committee.

Those HMOs (like Aetna) or drug companies who don't have lobbyists in Coakley's top tier of fundraisers? They're covered, because the host committee includes four lobbyists representing the Pharmaceutical Researchers and Manufacturers of America (PhRMA), two representing America's Health Insurance Plans (AHIP), and one representing the Biotechnology Industry Organization (BIO)

So think of these top donors to health-care reform's 60th vote next time President Obama claims that he's battling the special interests in this battle. The army listed below is on Obama's side, and these clients will all benefit from "reform."

Here are some of Coakley fundraiser hosts with some of their current health care clients:

•Thomas Boggs, Patton Boggs: Bristol-Myers Squibb
•Chuck Brain, Capitol Hill Strategies: Amgen, BIO, Merck, PhRMA
•Susan Brophy, Glover Park Group: Blue Cross, Pfizer
•Steven Champlin, Duberstein Group: AHIP, Novartis, Sanofi-Aventis
•Licy Do Canto, Raben Group: Amgen
•Gerald Cassidy, Cassidy & Associates: U. Mass Memorial Health Care
•David Castagnetti, Mehlman, Vogel, Castagnetti: Abbot Labs, AHIP, Astra-Zenaca, General Electric, Humana, Merck, PhRMA.
•Steven Elmendorf, Elmendorf Strategies: Medicines Company, PhRMA, United Health
•Shannon Finley, Capitol Counsel: Amgen, Astra-Zeneca, Blue Cross, GE, PhRMA, Sanofi-Aventis.
•Heather Podesta, Heather Podesta & Partners: Cigna, Eli Lilly, HealthSouth
•Tony Podesta, Podesta Group: Amgen, GE, Merck, Novartis.
•Robert Raben, Raben Group: Amgen, GE.
If Coakley pulls it out, this is the crowd that will have brought her here. If health-care reform passes, this is the crew that will have won.

Heard today that Obama may zip over to do some campaigning for Coakley this weekend. That shows that the race is very tight.
I prefer that Obama stay in Washington to deal with national security and jobs, rather than wasting fuel for which we taxpayers provide. This is not national business but political business.

Obama also campaigned for Corzine in NJ the entire weekend before he lost the Gov's race in NJ (spending 24 million of his own money by the way).

Also the current approval of Obama in MASS is 44% approve - 43% DISAPPROVE!

This was in the latest polls and that is why he did not go "campaigning" before this - basically half of the voters in MASS do not like Obama!